文献速递心律失常

人类单形性室速的血管迷走反应:窦率分析的血流动力学意义

Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Hemodynamic Implications From Sinus Rate Analysis.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

本研究回顾性分析150例瘢痕相关室速消融患者的261次室速发作,发现52%呈交感反应、31%窦率不变、17%呈迷走反应。不可耐受室速中不适当窦率反应比例显著高于可耐受室速(84% vs 34%,P<0.001)。前瞻性队列中阿托品使70%患者室速血流动力学耐受改善。

要点

  • 近半数室速发作未能增加窦率,提示存在未被充分认识的血管迷走反应。
  • 不适当窦率反应对血流动力学不稳定的预测价值优于室速频率和射血分数。
  • 阿托品可改善部分患者对室速的血流动力学耐受。

核心结论

  • 近半数室速发作与窦率未能增加相关,提示对室速的血管迷走反应被低估。
  • 不适当窦率反应比室速频率和射血分数更能预测血流动力学不稳定。
  • 迷走抑制治疗可能是提升室速时血压的新方法。

研究设计与样本

  • 回顾性分析接受瘢痕相关室速消融的患者,共150例、261次室速发作,中位室速持续时间1.6分钟。
  • 根据室速前及室速时窦性周期长度分析窦率反应,分为升高(≥5次/分,交感)、降低(≥5次/分,迷走)和不变,后两者归为不适当窦率反应。
  • 前瞻性队列(n=30)纳入窦率未能升高的患者,给予阿托品以评估对室速血流动力学耐受的影响。

主要发现

  • 261次室速发作中29%不可耐受、71%可耐受。
  • 52%室速发作呈交感反应,31%窦率不变,17%呈迷走反应。
  • 不可耐受室速(150秒内需电复律的持续性室速)中不适当窦率反应比例显著高于可耐受室速(84% vs 34%;P<0.001)。
  • 不可耐受室速比例在各组间显著不同:交感组9%、迷走组82%、不变组32%(P<0.001)。
  • 阿托品使70%患者的室速血流动力学耐受改善。

关键数值与推荐

  • 窦率升高定义为≥5次/分(交感反应),降低定义为≥5次/分(迷走反应),不变与降低归为不适当窦率反应。
  • 不可耐受室速定义为150秒内需电复律的持续性室速。
  • 不可耐受室速中不适当窦率反应占84%,可耐受室速中占34%(P<0.001)。
  • 不可耐受室速比例:交感组9%、迷走组82%、不变组32%(P<0.001)。
  • 阿托品使70%患者室速血流动力学耐受改善。

临床怎么用

  • 室速发作时可通过窦率变化识别血管迷走反应,辅助判断血流动力学耐受性。
  • 对窦率未能升高的室速患者,可考虑迷走抑制治疗以提升血压。
  • 窦率反应对血流动力学不稳定的预测价值优于室速频率和射血分数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Factors determining hemodynamic stability during human ventricular tachycardia (VT) are incompletely understood. OBJECTIVES: The purposes of this study were to characterize sinus rate (SR) responses during monomorphic VT in association with hemodynamic stability and to prospectively assess the effects of vagolytic therapy on VT tolerance. METHODS: This is a retrospective analysis of patients undergoing scar-related VT ablation. Vasovagal responses were evaluated by analyzing sinus cycle length before VT induction and during VT. SR responses were classified into 3 groups: increasing (≥5 beats/min, sympathetic), decreasing (≥5 beats/min, vagal), and unchanged, with the latter 2 categorized as inappropriate SR. In a prospective cohort (n = 30) that exhibited a failure to increase SR, atropine was administered to improve hemodynamic tolerance to VT. RESULTS: In 150 patients, 261 VT episodes were analyzed (29% untolerated, 71% tolerated) with median VT duration 1.6 minutes. A total of 52% of VT episodes were associated with a sympathetic response, 31% had unchanged SR, and 17% of VTs exhibited a vagal response. A significantly higher prevalence of inappropriate SR responses was observed during untolerated VT (sustained VT requiring cardioversion within 150 seconds) compared with tolerated VT (84% vs 34%; P < 0.001). Untolerated VT was significantly different between groups: 9% (sympathetic), 82% (vagal), and 32% (unchanged) (P < 0.001). Atropine administration improved hemodynamic tolerance to VT in 70%. CONCLUSIONS: Nearly one-half of VT episodes are associated with failure to augment SR, indicative of an under-recognized pathophysiological vasovagal response to VT. Inappropriate SR responses were more predictive of hemodynamic instability than VT rate and ejection fraction. Vagolytic therapy may be a novel method to augment blood pressure during VT.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Pujol-Lopez M, Du Fay de Lavallaz J, Rangan P, et al. Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Hemodynamic Implications From Sinus Rate Analysis. J Am Coll Cardiol. 2023. PMID: 37673510. doi:10.1016/j.jacc.2023.06.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。